Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,579

Sort by:

Acute Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Lung Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 80 pages

Acute Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 45 pages

Acute Opioid Overdosage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Opioid Overdosage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Opioid Overdosage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 43 pages

Acute Promyelocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Promyelocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Promyelocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 40 pages

Acute Respiratory Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Respiratory Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Respiratory Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 35 pages

Acute Sensorineural Hearing Loss Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Sensorineural Hearing Loss Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Sensorineural Hearing Loss Drugs in Development by Stages, Target, MoA, R...

May 2022 47 pages

Acute Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Acute Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Acute Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 42 pages

Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 295 pages

Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 116 pages

Adenocarcinoma Of The Gastroesophageal Junction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Adenocarcinoma Of The Gastroesophageal Junction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Adenocarcinoma Of The Gastroesophageal Junction Drugs in Develop...

May 2022 250 pages

Adenoid Cystic Carcinoma (ACC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Adenoid Cystic Carcinoma (ACC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Adenoid Cystic Carcinoma (ACC) Drugs in Development by Stages, Target, MoA, RoA,...

May 2022 60 pages

Adenosine Monophosphate Activated Protein Kinase ([Hydroxymethylglutaryl CoA Reductase (NADPH)] Kinase or AMPK or EC 2.7.11.31) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Adenosine Monophosphate Activated Protein Kinase ([Hydroxymethylglutaryl CoA Reductase (NADPH)] Kinase or AMPK or EC 2.7.11.31) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA,...

May 2022 103 pages

Adenosine Receptor A1 (ADORA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Adenosine Receptor A1 (ADORA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Adenosine Receptor A1 (ADORA1) Drugs in Development by The...

May 2022 47 pages

Adenosine Receptor A2a (ADORA2A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Adenosine Receptor A2a (ADORA2A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Adenosine Receptor A2a (ADORA2A) Drugs in Development by...

May 2022 80 pages

Adenoviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Adenoviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Adenoviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 57 pages

Adiponectin Receptor Protein 1 (Progestin And AdipoQ Receptor Family Member I or ADIPOR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Adiponectin Receptor Protein 1 (Progestin And AdipoQ Receptor Family Member I or ADIPOR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY...

May 2022 38 pages

ADP Ribosyl Cyclase-Cyclic ADP Ribose Hydrolase 1 (Cyclic ADP Ribose Hydrolase 1 or T10 or 2 Phospho ADP Ribosyl Cyclase-2 Phospho Cyclic ADP Ribose Transferase or ADP Ribosyl Cyclase 1 or CD38 or EC 3.2.2.6 or EC 2.4.99.20) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

ADP Ribosyl Cyclase-Cyclic ADP Ribose Hydrolase 1 (Cyclic ADP Ribose Hydrolase 1 or T10 or 2 Phospho ADP Ribosyl Cyclase-2 Phospho Cyclic ADP Ribose Transferase or ADP Ribosyl Cyclase 1 or CD38 or EC...

May 2022 49 pages

ADP Ribosylation Factor 6 (ARF6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

ADP Ribosylation Factor 6 (ARF6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY ADP Ribosylation Factor 6 (ARF6) Drugs in Development by...

May 2022 36 pages

Adrenal Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Adrenal Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Adrenal Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 68 pages

Ageing Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ageing Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ageing Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...

May 2022 86 pages

Aicardi-Goutieres Syndrome (AGS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Aicardi-Goutieres Syndrome (AGS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Aicardi-Goutieres Syndrome (AGS) Drugs in Development by Stages, Target, MoA, R...

May 2022 37 pages

Aldehyde Dehydrogenase Mitochondrial (ALDH Class 2 or ALDH E2 or ALDHI or ALDH2 or EC 1.2.1.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Aldehyde Dehydrogenase Mitochondrial (ALDH Class 2 or ALDH E2 or ALDHI or ALDH2 or EC 1.2.1.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SU...

May 2022 37 pages

Aldose Reductase (Aldehyde Reductase or Aldo Keto Reductase Family 1 Member B1 or AKR1B1 or EC 1.1.1.21) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Aldose Reductase (Aldehyde Reductase or Aldo Keto Reductase Family 1 Member B1 or AKR1B1 or EC 1.1.1.21) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 36 pages

ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY...

May 2022 67 pages

Alkaline Phosphatase (ALKP or Phosphomonoesterase or Glycerophosphatase or Alkaline Phosphohydrolase or EC 3.1.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Alkaline Phosphatase (ALKP or Phosphomonoesterase or Glycerophosphatase or Alkaline Phosphohydrolase or EC 3.1.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Ty...

May 2022 40 pages

Allergic Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Allergic Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Allergic Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 97 pages

Allergic Bronchopulmonary Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Allergic Bronchopulmonary Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Allergic Bronchopulmonary Aspergillosis Drugs in Development by Stages,...

May 2022 37 pages

Allergic Rhino-Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Allergic Rhino-Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Allergic Rhino-Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 43 pages

Alopecia Areata Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Alopecia Areata Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Alopecia Areata Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 60 pages

Alpha 1 Adrenergic Receptor (ADRA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Alpha 1 Adrenergic Receptor (ADRA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Alpha 1 Adrenergic Receptor (ADRA1) Drugs in Developm...

May 2022 67 pages

Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or SERPINA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or SERPINA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Al...

May 2022 64 pages

Alpha 1B Adrenergic Receptor (Alpha 1B Adrenoreceptor or ADRA1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Alpha 1B Adrenergic Receptor (Alpha 1B Adrenoreceptor or ADRA1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Alpha 1B Adrenergic Rece...

May 2022 37 pages

Alpha 2 Adrenergic Receptor (ADRA2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Alpha 2 Adrenergic Receptor (ADRA2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Alpha 2 Adrenergic Receptor (ADRA2) Drugs in Developm...

May 2022 68 pages

Alpha Adrenergic Receptor (ADRA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Alpha Adrenergic Receptor (ADRA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Alpha Adrenergic Receptor (ADRA) Drugs in Development by...

May 2022 101 pages

Alport Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Alport Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Alport Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 42 pages

Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Amin...

May 2022 39 pages

Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Amin...

May 2022 52 pages

Amino Acid Metabolism Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Amino Acid Metabolism Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Amino Acid Metabolism Disorders Drugs in Development by Stages, Target, MoA, RoA...

May 2022 107 pages

Anal Fissure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anal Fissure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anal Fissure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 37 pages

Anaplastic Large Cell Lymphoma (ALCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anaplastic Large Cell Lymphoma (ALCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anaplastic Large Cell Lymphoma (ALCL) Drugs in Development by Stages, Targ...

May 2022 112 pages

Anaplastic Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anaplastic Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anaplastic Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 64 pages

Androgen Receptor (Dihydrotestosterone Receptor or Nuclear Receptor Subfamily 3 Group C Member 4 or DHTR or NR3C4 or AR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Androgen Receptor (Dihydrotestosterone Receptor or Nuclear Receptor Subfamily 3 Group C Member 4 or DHTR or NR3C4 or AR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecu...

May 2022 136 pages

Androgen-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Androgen-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Androgen-Sensitive Prostate Cancer Drugs in Development by Stages, Target, Mo...

May 2022 35 pages

Androgenic Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Androgenic Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Androgenic Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 52 pages

Anemia of Chronic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anemia of Chronic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anemia of Chronic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 35 pages

Angelman Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Angelman Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Angelman Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 53 pages

Angioimmunoblastic T-Cell Lymphoma (AITL)-Immunoblastic Lymphadenopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Angioimmunoblastic T-Cell Lymphoma (AITL)-Immunoblastic Lymphadenopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Angioimmunoblastic T-Cell Lymphoma (AITL...

May 2022 96 pages

Angiopoietin 2 (Ang 2 or ANGPT2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Angiopoietin 2 (Ang 2 or ANGPT2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Angiopoietin 2 (Ang 2 or ANGPT2) Drugs in Development by...

May 2022 47 pages

Angiopoietin Related Protein 3 (Angiopoietin 5 or Angiopoietin Like Protein 3 or ANG 5 or ANGPTL3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Angiopoietin Related Protein 3 (Angiopoietin 5 or Angiopoietin Like Protein 3 or ANG 5 or ANGPTL3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Player...

May 2022 39 pages

Angiosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Angiosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Angiosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 64 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...